SCHEMBL19020634

SCHEMBL19020634

Nc1ccc(C(=O)Nc2ccc(-c3ccc(C(=O)Nc4cccc5cccc(S(=O)(=O)O)c45)cc3)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD40 P25942 4/20 0.77
CD40LG P29965 4/20 0.77
PRMT1 Q99873 3/20 0.54
SETD7 Q8WTS6 1/20 0.54
MEN1 O00255 2/20 0.50
POLB P06746 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50
PKM P14618 1/20 0.50
APEX1 P27695 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
TTR P02766 1/20 0.47
FABP4 P15090 1/20 0.47
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
MAPK14 Q16539 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19020654 0.95 CD40 (0.69) CD40CD40LGPRMT1SETD7MEN1
SCHEMBL19020632 0.87 CD40 (1.00) CD40CD40LGMEN1KMT2ALMNA
SCHEMBL20590980 0.85 CD40 (1.00) CD40CD40LGMEN1POLBKMT2A
SCHEMBL11500762 0.82 CD40 (0.53) CD40CD40LGPRMT1SETD7MEN1
SCHEMBL23736041 0.82 CD40 (0.55) CD40CD40LGPRMT1SETD7MEN1
SCHEMBL11435576 0.80 CD40 (0.50) CD40CD40LGMEN1POLBKMT2A
SCHEMBL19021224 0.80 CD40 (0.92) CD40CD40LGMEN1POLBKMT2A
SCHEMBL11436100 0.79 CD40 (0.49) CD40CD40LGMEN1POLBKMT2A
SCHEMBL6242038 0.79 CD40 (0.61) CD40CD40LGMEN1KMT2APKM
SCHEMBL19020655 0.79 CD40 (0.87) CD40CD40LGMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389781-B1 INHIBITORS OF TNF SUPERFAMILY COSTIMULATORY INTERACTIONS AND METHODS FOR USES OF THE SAME UNIV MIAMI (US) 2021-08-11 EP disclosed
US-10562848-B2 Inhibitors of TNF superfamily costimulatory interactions and methods for uses of the same UNIVERSITY OF MIAMI (US) 2020-02-18 US disclosed
WO-2017106436-A1 INHIBITORS OF TNF SUPERFAMILY COSTIMULATORY INTERACTIONS AND METHODS FOR USES OF THE SAME UNIVERSITY OF MIAMI (US) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10562848-B2 Inhibitors of TNF superfamily costimulatory interactions and methods for uses of the same CD40, TNFRSF9, TNFRSF1A CD40 1/4885CD40LG 7/4885PRMT1 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.